| Identification | Back Directory | [Name]
Paroxetine EP IMpurity G | [CAS]
69675-10-1 | [Synonyms]
Paroxetine USP RC E
Paroxetine impurity G
Paroxetine EP IMpurity G
Paroxetine impurities804
Paroxetine Anhydrous EP Impurity G
Paroxetine HCl Hemihydrate EP Impurity G
Paroxetine Hydrochloride Anhydrous EP Impurity G
Paroxetine hydrochloride hemihydrate EP Impurity G
4-(4-fluorophenyl)-1-methyl-3,6-dihydro-2H-pyridine
4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine
Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl-
Paroxetine Impurity 1(Paroxetine HCl Hemihydrate EP Impurity G)
Paroxetine Impurity 1 Monomer（Paroxetine HCl Hemihydrate EP Impurity G Monomer） | [Molecular Formula]
C12H14FN | [MOL File]
69675-10-1.mol | [Molecular Weight]
191.24 |
| Chemical Properties | Back Directory | [Boiling point ]
264.5±40.0 °C(Predicted) | [density ]
1.079±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
8.63±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
4-(4-Fluorophenyl)-1,2,3,6-tetrahydro-1-methylpyridine (Paroxetine EP Impurity G) is a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs which inhibit the oxidation of benyzlamine by bovine plasma amine oxidase. Suitable as substrates for monoamine oxidase B and possesses dopaminergic neurotoxicity. |
|
|